SCHEMBL10696067

SCHEMBL10696067

COc1ccc(CCN(C)Cc2ccccc2)c2c1NCCC2

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ POLB P06746 1/20 0.45
▸ PARP1 P09874 8/20 0.44
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ HTR6 P50406 1/20 0.43
▸ KDM4E B2RXH2 7/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ BLM P54132 1/20 0.42
▸ BCHE P06276 1/20 0.42
▸ ALDH1A1 P00352 3/20 0.41
▸ TDP1 Q9NUW8 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10698080 0.76 PARP1 (0.45) SMN1; SMN2POLBPARP1KDM4EGAA
SCHEMBL10694640 0.73 ALDH1A1 (0.44) SMN1; SMN2POLBMEN1KMT2AKDM4E
SCHEMBL13579948 0.72 BCHE (0.69) SMN1; SMN2POLBMEN1KMT2AHTR6
SCHEMBL10840554 0.69 ADRA1D (0.55) SMN1; SMN2KDM4EMAPT
SCHEMBL29187807 0.68 PARP1 (0.47) PARP1
SCHEMBL10390463 0.68 KDM4E (0.80) SMN1; SMN2MEN1KMT2AKDM4ECYP1A2
SCHEMBL10840999 0.67 HTR1A (0.52) PARP1KDM4EALDH1A1
SCHEMBL14768407 0.66 MEN1 (0.47) SMN1; SMN2POLBMEN1KMT2AHTR6
SCHEMBL5464408 0.66 PARP1 (0.44) PARP1KDM4EALDH1A1GAA
SCHEMBL2271969 0.65 PARP1 (0.45) PARP1CYP3A4ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4792559-A 1,2,3,4-tetrahydroquinoline substituted 5-aminopentanenitrile compounds and their use as calcium modulators ADIR ET COMPAGNIE (FR) 1988-12-20 — — US disclosed
EP-0275101-A2 Novel peptidase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1988-07-20 — — EP disclosed
Send feedback